share_log

Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development

Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development

新聞稿:Green Hygienics Holdings Inc.(GRYN)任命David racz為負責全球銷售和業務發展的高級副總裁
Dow Jones Newswires ·  2021/07/27 08:34

Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development

新聞稿:Green Hygienics Holdings Inc.(GRYN)任命David racz為負責全球銷售和業務發展的高級副總裁

Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development

綠色衞生控股公司(GRYN)任命大衞·拉茨為負責全球銷售和業務發展的高級副總裁

SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior Vice President of Global Sales and Business Development.

聖迭戈,2021年7月27日(環球網)--通過InvestorWire--Green Hygienics Holdings Inc.(場外交易市場代碼:GRYN)(以下簡稱“Green Hygienics”或“公司”)宣佈任命大衞·拉茨為負責全球銷售和業務發展的高級副總裁。

Mr. David Racz has held global, senior level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline, and Novartis. He began his pharmaceutical career at Pfizer Pharmaceuticals where he became vice president of sales and human resources and managed the largest expansion in Pfizer's sales force in history.

David racz先生曾在輝瑞、葛蘭素史克和諾華等知名製藥公司擔任全球高級職位。他在輝瑞製藥公司(Pfizer PharmPharmticals)開始了他的製藥生涯,在那裏他成為負責銷售和人力資源的副總裁,並管理着輝瑞歷史上最大規模的銷售隊伍擴張。

Shortly thereafter, SmithKline Beecham recruited David to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia, and South Africa in sales, marketing, and research and development. He was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham.

此後不久,SmithKline Beecham招聘了David,在亞洲、拉丁美洲、澳大利亞和南非的20個國家和地區管理4000多名員工,從事銷售、營銷和研發工作。他也是負責策劃史無前例的史密斯克萊恩(SmithKline)和比徹姆(Beecham)跨洲合併的團隊的關鍵成員。

In 2002, David was recruited by Novartis Pharmaceuticals as senior vice president North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in pharmaceutical operations, global oncology, manufacturing and R&D.

2002年,大衞被諾華製藥公司聘為北美高級副總裁。在這一職位上,他為一家價值80億美元的醫療保健公司提供戰略和資源分配,並監督製藥業務、全球腫瘤學、製造和研發領域的1.4萬名全球員工。

Further, David was Senior Vice President for Mona Vie Inc. ("Mona Vie"), the fastest-growing private company in the food and beverage industry. With annual sales in excess of $942 million, David facilitated growth exceeding 100% per quarter, year over year, while in this role.

此外,大衞是Mona Vie Inc.(“Mona Vie”)的高級副總裁,Mona Vie是食品和飲料行業增長最快的私營公司。大衞在擔任這一職務期間,年銷售額超過9.42億美元,推動了每季度超過100%的同比增長。

Over the past 10 years David has amassed a wealth of knowledge and experience in the cannabis industry. He began his cannabis career in 2008, in Colorado where he worked with legislative bodies to develop the then emerging medical cannabis laws.

在過去的10年裏,大衞積累了豐富的大麻行業知識和經驗。他於2008年在科羅拉多州開始了他的大麻職業生涯,在那裏他與立法機構合作,制定了當時新興的醫用大麻法律。

In 2011 working under multiple controlled substance license(s) issued from The Canadian Department of Health, David led a team that was responsible for:

2011年,大衞根據加拿大衞生部頒發的多種受控物質許可證開展工作,他領導的團隊負責:

-- Acquisition and/or application of 6 cannabinoid related patents -- Discovery of 2 previously unidentified cannabis chemical structures -- Amassed a cannabis DNA library of over 4000 strains -- Early advancement of cannabis genetic engineering for application in large scale production.

--獲得和/或應用6項與大麻素相關的專利--發現2種以前未被識別的大麻化學結構--積累了4000多種大麻DNA文庫--大麻基因工程的早期進展,用於大規模生產。

He has served as a U.S. Army medical service corps officer, achieving the rank of major, and was awarded numerous times for service and merit. David earned his bachelor's degree from Wayne State University and his master's degree from Troy University.

他曾擔任美國陸軍醫療服務隊軍官,獲得少校軍銜,並多次因服務和功績而被授予榮譽。大衞在韋恩州立大學獲得學士學位,在特洛伊大學獲得碩士學位。

About Green Hygienics Holdings Inc.

關於Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company's corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

綠色衞生控股公司(場外交易市場代碼:GRYN)(以下簡稱“Green Hygienics”或“公司”)是一家總部設在加利福尼亞州的創新、技術驅動型企業,專注於工業大麻的高標準種植和加工,以及製藥級生物活性大麻的製造。該公司的公司使命是堅持最高的運營標準,始終如一地向消費者提供安全和優質的產品,並與CPG(消費品)和製藥公司建立合作伙伴關係。

Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.

衞生學是保護和促進個人、社區和地球健康的科學。

For further information about Green Hygienics Holdings Inc., please visit the Company's website at: http://www.greenhygienics.com/

欲瞭解有關綠色衞生控股公司的更多信息,請訪問公司網站:http://www.greenhygienics.com/。

Follow us on Facebook, Twitter, Instagram and Linkedin

在Facebook、Twitter、Instagram和LinkedIn上關注我們

Corporate Communications:

企業通信:

Heidi Thomasen

海蒂·托馬森

IR@GreenHygienics.com

郵箱:ir@GreenHygienics.com

Toll Free 1.855.802.0299

免費電話1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

關於前瞻性陳述的警告性聲明

This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

本文檔包含前瞻性陳述。在評估這些前瞻性陳述時,您應該考慮各種因素,包括我們改變公司方向的能力;我們跟上新技術和不斷變化的市場需求的能力;以及我們業務的競爭環境。這些因素和其他因素可能導致我們的實際結果與任何前瞻性陳述大不相同。

Public Relations:

公共關係:

InvestorBrandNetwork (IBN)

投資者品牌網絡(IBN)

Los Angeles, California

加利福尼亞州洛杉磯

www.InvestorBrandNetwork.com

Www.InvestorBrandNetwork.com

310.299.1717 Office

310.299.1717辦事處

Editor@InvestorBrandNetwork.com

電子郵箱:Editor@InvestorBrandNetwork.com

(END) Dow Jones Newswires

(完)道瓊通訊社

July 27, 2021 08:34 ET (12:34 GMT)

2021年7月27日東部時間08:34(格林尼治標準時間12:34)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論